Search Results - "Skuridin, D"

OBSTRUCTIVE SLEEP APNEA, GALECTIN-3 AND ATRIAL FIBRILLATION IN PATIENTS WITH OBESITY AND HYPERTENSION by Ionin, V, Filatova, A, Skuridin, D, Petrischeva, E, Zaslavskaya, E, Baranova, E

“…OBJECTIVE:Obstructive sleep apnea (OSA) – risk factor of atrial fibrillation (AFib) especially in patients with obesity and hypertension, but pathogenesis is…”
Get full text

Reasons for not prescribing anticoagulants in hospitalized patients with atrial fibrillation and high risk of stroke: what should be the optimal management tactics for these patients? by Baranova, E. I., Bliznyuk, O. I., Pavlova, V. A., Skuridin, D. S., Kolesnik, O. S., Katsap, A. A.

“…The objective of our study was to determine the reasons for not prescribing anticoagulant therapy (ACT) in the therapeutic department of university clinic for…”
Get full text

Atrial fibrillation and CHA2DS2VASc score of 1 - is there a problem in clinical practice? by Baranova, E. I., Pavlova, V. A., Ionin, V. A., Petrischeva, E. Yu, Bliznuk, O. I., Zaslavskaya, E. L., Ma, I., Skuridin, D. S., Shlakhto, E. V.

“…Aim. To study the incidence of nonvalvular atrial fibrillation (AF) in patients with a CHA2DS2VASc score of 1 in actual clinical practice, to determine the…”
Get full text

Anticoagulant therapy and components of the metabolic syndrome in patients with atrial fibrillation in real outpatient clinical practice by Ionin, V. A., Petrischeva, E. Yu, Skuridin, D. S., Bliznyuk, O. I., Ivanova, A. A., Filatova, A. E., Ma, I., Zaslavskaya, E. L., Baranova, E. I.

“…The aim of the study was to determine the prevalence of atrial fibrillation (AF) in patients hospitalized in the therapeutic and cardiology departments of the…”
Get full text

Arterial Stiffness, Galectin-3, Tgf-Beta1 And Diastolic Dysfunction In Patients With Atrial Fibrillation by Ionin, V., Skuridin, D., Petrisheva, E., Zaslavskaya, E., Polyakova, E., Belyaeva, O., Baranova, E., Shlyakhto, E.

Get full text

ARTERIAL STIFFNESS, ALDOSTERONE, CRP AND DIASTOLIC DYSFUNCTION IN PATIENTS WITH HYPERTENSION, OBESITY AND ATRIAL FIBRILLATION by Ionin, V., Skuridin, D., Petrisheva, E., Zaslavskaya, E., Bazhenova, E., Babenko, A., Baranova, E., Shlyakhto, E.

Get full text

P3757Profibrogenic biomarkers and severity of left atrial fibrosis in patients with atrial fibrillation and metabolic syndrome: is it possible to predict the effectiveness of therapy? by Ionin, V A, Zaslavskaya, E L, Morozov, A N, Skuridin, D S, Petrishcheva, E Y U, Ma, Y, Yashin, S M, Baranova, E I, Shlyakhto, E V

“…Abstract Background Galectin-3 (Gal-3) and transforming growth factor-beta1 (TGFbeta1) – biomarkers of fibrosis are increased in patients with atrial…”
Get full text

Surface and crystal structure of nitridated sapphire substrates and their effect on polar InN layers by Skuridina, D., Dinh, D.V., Pristovsek, M., Lacroix, B., Chauvat, M.-P., Ruterana, P., Kneissl, M., Vogt, P.

“…•Surface reconstructions of sapphire substrates upon thermal annealing.•Atomic structures of amorphous and crystalline thin nitridated sapphire…”
Get full text

Cardiotrophin-1 and components of metabolic syndrome: what is the role in the development of atrial fibrillation? by Ionin, V, Zaslavskaya, EL, Barashkova, EI, Skuridin, DS, Baranova, EI, Shlyakhto, EV

Get full text